We operate at the frontiers of computational biology, chemistry, and artificial intelligence, developing new techniques and technologies that have the potential to revolutionize biomedical research and drug discovery.
Under review
Using SARS-CoV-2 proteomes to predict probability of host mortality in conjuction with patient genomic and phenotypic factors.
In progress
Attention-based natural language networks applied to cohort identification, retrieval, and analysis.
In progress
An end-to-end biomedical discovery system designed for the future of artifical intelligence and biology, democratizating novel discoveries to the masses.
OUR COMMITMENT TO OPEN SOURCE
Fostering open research on COVID-19 by providing our tools for free to biologists, chemists, and data scientists researching COVID-19.
Quantifying the spread of misinformation in the social graph using the world's most popular public discourse forum, Twitter. Development inspired by the COVID-19 pandemic.
Automatically crawling and integrating patient medical records and commercial genomic data into Omic OS. Contribute your anonymized data for the acceleration of science.